
Sanofi SA
PAR:SAN

US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
82.81
109.62
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.

Intrinsic Value
The intrinsic value of one
SAN
stock under the Base Case scenario is
90.4
EUR.
Compared to the current market price of 83.07 EUR,
Sanofi SA
is
Undervalued by 8%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Sanofi SA
Historical valuation for SAN cannot be conducted due to limitations such as insufficient data or other constraints.
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:


Revenue & Expenses Breakdown
Sanofi SA
Balance Sheet Decomposition
Sanofi SA
Current Assets | 44B |
Cash & Short-Term Investments | 8B |
Receivables | 447m |
Other Current Assets | 35.6B |
Non-Current Assets | 87.9B |
PP&E | 11.4B |
Intangibles | 63.8B |
Other Non-Current Assets | 12.7B |
Current Liabilities | 32.2B |
Accounts Payable | 21.6B |
Other Current Liabilities | 10.6B |
Non-Current Liabilities | 25.6B |
Long-Term Debt | 13.4B |
Other Non-Current Liabilities | 12.2B |
Free Cash Flow Analysis
Sanofi SA
EUR | |
Free Cash Flow | EUR |
Earnings Waterfall
Sanofi SA
Revenue
|
91.5B
EUR
|
Cost of Revenue
|
-27B
EUR
|
Gross Profit
|
64.5B
EUR
|
Operating Expenses
|
-44B
EUR
|
Operating Income
|
20.5B
EUR
|
Other Expenses
|
-7.8B
EUR
|
Net Income
|
12.7B
EUR
|
SAN Profitability Score
Profitability Due Diligence
Sanofi SA's profitability score is 60/100. The higher the profitability score, the more profitable the company is.

Score
Sanofi SA's profitability score is 60/100. The higher the profitability score, the more profitable the company is.
SAN Solvency Score
Solvency Due Diligence
Sanofi SA's solvency score is 49/100. The higher the solvency score, the more solvent the company is.

Score
Sanofi SA's solvency score is 49/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
SAN Price Targets Summary
Sanofi SA
According to Wall Street analysts, the average 1-year price target for
SAN
is 115.94 EUR
with a low forecast of 95.95 EUR and a high forecast of 133.35 EUR.
Dividends
Current shareholder yield for SAN is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
SAN
stock under the Base Case scenario is
90.4
EUR.
Compared to the current market price of 83.07 EUR,
Sanofi SA
is
Undervalued by 8%.